This newly discovered mechanism highlights the involvement of AR in modulating the circ-SLCO1B7/miR-139-5p/TPD52 signaling pathway, which impacts the progression of NSCLC cells. The gene discussed is TPD52; the disease is non-small cell lung carcinoma.